NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Dang... the description mentions all solid tumors!

so? they first have to in the future start planning the idea of going about conducting the first layout of the possibility of clinical trials of DCVax-L for other types of solid tumor cancers, beyond brain cancer, when and if resources permit.

NWBO will NEVER obtain approval for DCVax-L for other types of solid tumor cancers, beyond brain cancer for the simple reason that NWBO will not exist anymore after DCVAXL for GBM will be approved.

This is Dr. Bosch pitching to Merck that he wants to be employed by Merck and continue with all Direct, combo, and DCVAXL trials after Merck has bought NWBO at Merck.